The Cooper Companies, Inc.
COO
Rang in Aktien
#1899
The Cooper Companies, Inc. (COO) operates as a global medical device firm,... The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.
Aktienkurs
$58.95
Marktkapitalisierung
$11.21B
Veränderung (1 Tag)
1.36%
Veränderung (1 Jahr)
-21.39%
Land
US
Handel The Cooper Companies, Inc. (COO)
Kategorie
Healthcare
Anzahl der ausstehenden Aktien von The Cooper Companies, Inc. (COO)
Anzahl der ausstehenden Aktien zum July 2026: 193.40M
Laut den neuesten Finanzberichten und dem Aktienkurs von The Cooper Companies, Inc. beträgt die aktuelle Anzahl der ausstehenden Aktien 193.40M. Am Ende von October 2024 hatte das Unternehmen 198.90M ausstehende Aktien. Die Anzahl der ausstehenden Aktien wird normalerweise durch Aktiensplits und Aktienrückkäufe beeinflusst.
Verlauf der ausstehenden Aktien von The Cooper Companies, Inc. (COO) von 2000 bis 2026
Ausstehende Aktien am Ende jedes Jahres
| Jahr | Ausstehende Aktien | ändert |
|---|---|---|
| 2026 (TTM) | 193.40M | -3.30% |
| 2025 | 200.00M | 0.55% |
| 2024 | 198.90M | 0.45% |
| 2023 | 198.00M | 0.41% |
| 2022 | 197.20M | 0.00% |
| 2021 | 197.20M | 0.41% |
| 2020 | 196.40M | -0.41% |
| 2019 | 197.20M | 0.41% |
| 2018 | 196.40M | 0.41% |
| 2017 | 195.60M | 0.82% |
| 2016 | 194.00M | 0.00% |
| 2015 | 194.00M | 0.91% |
| 2014 | 192.24M | -1.14% |
| 2013 | 194.46M | 1.47% |
| 2012 | 191.65M | 2.15% |
| 2011 | 187.62M | 3.02% |
| 2010 | 182.12M | 0.79% |
| 2009 | 180.69M | 0.40% |
| 2008 | 179.98M | 0.64% |
| 2007 | 178.83M | 0.42% |
| 2006 | 178.09M | 7.91% |
| 2005 | 165.03M | 27.07% |
| 2004 | 129.87M | 3.98% |
| 2003 | 124.90M | 2.19% |
| 2002 | 122.23M | 2.98% |
| 2001 | 118.70M | 4.57% |
| 2000 | 113.50M | 0.00% |
Ausstehende Aktien bei ähnlichen Unternehmen oder Wettbewerbern
| Unternehmen | Ausstehende Aktien | Unterschied | Land |
|---|---|---|---|
| 354.50M | 83.30% |
US
|
|
| 461.20M | 138.47% |
FR
|
|
| - | - |
JP
|
|
| 274.79M | 42.08% |
US
|
|
| - | - |
CH
|
